… Lung cancer remains the leading cause of cancer-related deaths worldwide, with non-small cell lung cancer (NSCLC) accounting for the…
Browsing: Non-Small Cell Lung Cancer
… At the MOASC Annual Oncology Summit & Research Symposium, Dr. Karen Reckamp, MD, MS, a leading figure in medical…
March 1, 2024 – In a significant advancement for lung cancer treatment, the Food and Drug Administration (FDA) has approved…
On February 16, 2024, the Food and Drug Administration (FDA) announced the approval of osimertinib, marketed under the brand name…
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
By. Josina Reddy, MDDate. 11/24/2023Today, the focus is on the ALINA trial, a phase three study comparing Alectinib versus chemotherapy…
By. Arta Monjazeb, MDDate: 11/21/2023Arta Monir Monjazeb, MD, explores cancer immunotherapy with a detailed discussion on the immune response, radiation’s…
By. Nicolas Rigard, MDDate. 11/20/2023In this interview, Nicolas Girard, MD, a medical doctor and professor of respiratory medicine at Versailles,…
By. Crispin Hiley, PhD Date. 11/17/2023 Crispin Hiley, PhD, from the UCL Cancer Institute in London, UK, discusses developments in…
By. Nicolas Girard, MD Date: 11/15/2023 In a significant development in the field of oncology, Nicolas Girard, MD, played a…
By. Aaron E. Lisberg, MD, Date. 11/14/2023 During ESMO 2023, Aaron E. Lisberg, MD, delivered a presentation on the results…
By: Dr. Rahul Gusain, MD Dr. Rohit Gusain, MD Dr. Joshua Reuss, MD Date:…
By: Byoung Chul Cho, MD, PhD, Yonsei University, Seoul, Korea, Date: 11/03/2023 Courtesy: VJOncology Above is a video from Byoung…
By. Antonio Passaro, MDDate. October 31, 2023Antonio Passaro, MD, an oncologist specializing in lung cancer, has been deeply involved in…
Author: Dr Herbert Ho Fung Loong (on-camera comments) – Courtesy of ESMO.org During ESMO 2023, I’ve had the pleasure of presenting…
By: Allen Wilbanks Date: September 29, 2023 In the groundbreaking Phase 3 LUNAR study led by Dr. Ticiana Leal, MD,…
Allen Wilbanks asked Ticiana Leal, MD from the Winship Cancer Institute of Emory University, about her thoughts on the overall…
Ticiana Leal, MD, a distinguished oncologist from the Winship Cancer Institute of Emory University, shared her insights during a discussion…
In a recent discussion on the long-term efficacy and safety of TT field treatment for lung cancer, Allen Wilbanks raised…
In a recent discussion, Ticiana Leal, MD, sheds light on TD Fields treatment for non-small cell lung cancer. This innovative…
In this informative video, viewers will gain valuable insights into the groundbreaking research discussed by medical experts Ticiana Leal, MD,…
In a groundbreaking lunar trial, Ticiana Leal, MD, a distinguished expert from the Winship Cancer Institute of Emory University, spearheaded…
In a conversation hosted by Allen Wilbanks, Solange Peters, MD, PhD, a full professor and chair of medical oncology specializing…
Jack West, MD is an associate professor in medical oncology specializing in thoracic oncology at the City of Hope Comprehensive…
In the pivotal phase 3 LUNAR study, Ticiana Leal, MD, and her colleagues made a groundbreaking discovery that could revolutionize…
IMpower010 & Atezolizumab: The trial has cemented the significance of atezolizumab in the potential treatment options for lung cancer, especially…
Dr. Jack West,MD an associate professor in medical oncology at City of Hope Comprehensive Cancer Center in Los Angeles, discussed…
In the dynamic world of oncology, chemotherapy stands as a beacon of hope for many battling the formidable challenge of…
Spotlight on Oncology: Exploring the Latest Advances in Lung Cancer Research Date: August 12, 2023 Speaker: Sai-Hong Ignatius Ou, MD…
Tune in to the 2022 Targeted Therapies Forum to explore the critical role of nutrition in cancer treatment, discussed by…
Navigating the world of cancer care requires ample support for patients and their caregivers. In this enlightening video, Dr. Aakash…
Opening up to loved ones about a cancer diagnosis is a deeply personal and often challenging experience. In this thought-provoking…
Understanding when to adjust cancer treatment is paramount in patient care. In this crucial session, Drs. Desai, Khalil, and Luo…
The landscape of treating KRAS+ NSCLC (Non-Small Cell Lung Cancer) is evolving, and understanding how to approach patient care after…
Handling the stress associated with cancer scans is a vital aspect of care for both patients and healthcare professionals. In…
Drs. Khalil, Luo, Desai, and Preeshagul in this insightful video from the 2022 Targeted Therapies Forum as they discuss effective…
Dr. Maya Khalil dives into the intricacies of RET+ NSCLC treatments in our 2022 Targeted Therapies Forum. Gain insights as…
In the esteemed 2022 Targeted Therapies Forum, Dr. Jia Luo, renowned Medical Oncologist from Dana-Farber Cancer Institute and respected Instructor…
In an inspiring session from the 2022 Targeted Therapies Forum, Terri Conneran, lung cancer survivor and the visionary Founder of…